Clinical Trial

An Outcome Analysis of Primary Membranous Nephropathy

Study acronym: PROMENADE
Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational study intended to track the course of the primary membranous nephropathy disease in real-world clinical practice. The study will primarily assess the long-term outcomes of patients with primary membranous nephropathy in the context of advances in treatment options.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-02-02; most recent amendment 2026-03-19.
Status change: Active, Not Recruiting → Recruiting 2026-03-19
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-08-28
Trial Details
NCT Number NCT06242327
Lead Sponsor Mario Negri Institute for Pharmacological Research
Conditions Membranous Nephropathy
Enrollment 500 participants
Start Date 2024-11-29
Primary Completion 2029-06 (estimated)
Study Completion 2054-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-23